The Supervisory Board of R. STAHL AG and Dr. Claus Bischoff, Chairman of the Management Board, have mutually agreed to end their cooperation as of 31 May 2026. Dr. Bischoff resigned from his office with immediate effect at his own request and for personal reasons. Management Board member Tobias Popp will assume responsibility for the division previously managed by Dr. Bischoff until further notice. The Supervisory Board has already initiated steps for further succession planning.
Dr. Bischoff's departure marks a significant transition for R. STAHL, a leading supplier of explosion protection products and systems. The Supervisory Board expressed gratitude for Dr. Bischoff's commitment, particularly for his role in the economic stabilization of the company and the development of the NEXUS future program. This program, aimed at future-proof market positioning, portfolio alignment, structural development, and sustainable internationalization, will be continued by Tobias Popp in coordination with the Supervisory Board and adapted to rapidly changing conditions.
The resignation comes at a time when R. STAHL is navigating a dynamic industrial landscape. The company, which generated global sales of approximately EUR 313 million in 2025 with 1,659 employees, serves critical sectors such as chemical, pharmaceutical, oil and gas, and food and beverage industries. Its products are also approved for use with hydrogen, aligning with global energy transition trends.
The Supervisory Board regrets Dr. Bischoff's departure and wishes him well. The company's shares are traded on the Regulated Market/Prime Standard of Deutsche Boerse (ISIN DE000A1PHBB5). For more information about R. STAHL, visit www.r-stahl.com.
This leadership change underscores the importance of continuity in corporate strategy. The NEXUS program, which Dr. Bischoff championed, remains central to R. STAHL's future. The company's ability to adapt its portfolio and internationalization efforts will be closely watched by investors and industry observers. As Tobias Popp steps in, the focus will be on maintaining momentum while addressing evolving market demands.
The resignation also highlights personal factors that can influence corporate leadership. While the specific reasons for Dr. Bischoff's departure were not disclosed, the mutual agreement suggests a planned transition. The Supervisory Board's proactive approach to succession planning indicates a commitment to stability.
In conclusion, Dr. Bischoff's resignation represents a pivotal moment for R. STAHL. The company's strategic direction, particularly the NEXUS program, will continue under new leadership. The implications for stakeholders include potential shifts in management style and strategic emphasis, but the core objectives of innovation and market expansion remain unchanged.
